{"latest_checked": "2026-10-14T12:30:18.613659+00:00", "coverage_count": 5027, "intelligence": {"score": 83, "label": "Broad acquisition tilt", "tone": "positive", "stance": "Check participation, transaction context and price together", "brief": "Priced common-share acquisitions outweigh disposals across the participating insiders. Each qualifying company has equal weight in this group reading.", "confidence": 30, "confidence_label": "Purpose not verified", "filings": 8, "companies": 1, "qualified_companies": 1, "insiders": 3, "signal_events": 4, "acquisition_events": 4, "disposal_events": 0, "acquisition_share": 100.0, "disposal_share": 0.0, "acquisition_value": 111818.32, "disposal_value": 0.0, "net_value": 111818.32, "acquisition_value_label": "$111.8K", "disposal_value_label": "$0", "net_value_label": "$111.8K", "data_quality": 62, "priced_common_share": 50, "latest_date": "2026-09-29", "latest_signal_date": "2026-09-29", "oldest_date": "2026-09-16", "recent_acquirers": 0, "cluster_companies": 0, "repeat_acquirers": 0, "largest_person_share": 39, "acquisition_companies": 1, "disposal_companies": 0, "method_version": "insider-2.0", "purpose_verified": false, "evidence_classes": [{"key": "common_equity", "label": "Common equity", "count": 4, "bar_width": 100.0}, {"key": "equity_award", "label": "Equity compensation", "count": 0, "bar_width": 0.0}, {"key": "derivative", "label": "Options and derivatives", "count": 4, "bar_width": 100.0}, {"key": "other", "label": "Other securities", "count": 0, "bar_width": 0.0}], "roles": [{"label": "Director", "count": 6, "bar_width": 100.0}, {"label": "Finance leadership", "count": 2, "bar_width": 33.3}], "supports": ["4 priced common-share events after duplicate controls.", "3 named participants across 1 companies."], "risks": ["Transaction codes, filing dates and trading-plan flags are not supplied. Acquisitions are not verified discretionary purchases.", "The latest usable transaction is more than two weeks old."]}, "freshness": {"total": 5027, "checked": 4982, "errors": 45, "latest": "2026-10-14T12:30:18.613Z", "session": "2026-10-14", "share": 99.1, "pending": 45}, "participation": [{"date": "2026-07-27", "acquirers": 0, "disposers": 0}, {"date": "2026-08-03", "acquirers": 0, "disposers": 0}, {"date": "2026-08-10", "acquirers": 0, "disposers": 0}, {"date": "2026-08-17", "acquirers": 0, "disposers": 0}, {"date": "2026-08-24", "acquirers": 0, "disposers": 0}, {"date": "2026-08-31", "acquirers": 0, "disposers": 0}, {"date": "2026-09-07", "acquirers": 0, "disposers": 0}, {"date": "2026-09-14", "acquirers": 1, "disposers": 0}, {"date": "2026-09-21", "acquirers": 1, "disposers": 0}, {"date": "2026-09-28", "acquirers": 1, "disposers": 0}, {"date": "2026-10-05", "acquirers": 0, "disposers": 0}, {"date": "2026-10-12", "acquirers": 0, "disposers": 0}], "recent_count": 8, "transaction_limit": 160, "filters": {"q": "", "ticker": "RLYB", "sector": "", "industry": "", "side": "", "start": "2026-07-17", "end": "2026-10-14"}, "summary": {"total": 8, "acquisition_count": 4, "disposal_count": 4, "acquisition_value": 111818.32, "acquisition_value_label": "$111.8K", "disposal_value": 47499.2, "disposal_value_label": "$47.5K", "net_value": 64319.12, "net_value_label": "$64.3K", "flow_tone": "positive", "largest_value_label": "$64.5K", "top_sector": "Healthcare", "window_label": "17 Jul 2026 to 14 Oct 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 8, "value": "159317.5200", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$159.3K"}], "days": [{"transaction_date": "2026-09-16", "acquisitions": 1, "disposals": 1, "total": 2, "bar_width": 50.0}, {"transaction_date": "2026-09-24", "acquisitions": 2, "disposals": 2, "total": 4, "bar_width": 100.0}, {"transaction_date": "2026-09-29", "acquisitions": 1, "disposals": 1, "total": 2, "bar_width": 50.0}], "side_mix": {"acquisitions": 4, "disposals": 4, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "RLYB", "name": "Rallybio Corp", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-29", "acquisitions": 4, "disposals": 1, "acquired_value": 111818.32, "acquired_value_label": "$111.8K", "disposed_value": 47499.2, "disposed_value_label": "$47.5K", "net_value": 64319.12, "net_value_label": "$64.3K", "acquisition_share": 80.0, "disposal_share": 20.0, "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}], "company_overview": [{"symbol": "RLYB", "name": "Rallybio Corp", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-29", "filings": 8, "acquisitions": 4, "disposals": 4, "acquired_value": 111818.32, "acquired_value_label": "$111.8K", "disposed_value": 47499.2, "disposed_value_label": "$47.5K", "net_value": 64319.12, "net_value_label": "$64.3K", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}], "transactions": [{"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-29", "executive": "LIEBER, JONATHAN I", "executive_title": "Chief Financial Officer", "security_type": "Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-29", "executive": "LIEBER, JONATHAN I", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5000.0, "share_price": 6.08, "transaction_value": 30400.0, "transaction_value_label": "$30.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-24", "executive": "LIU, HUI", "executive_title": "Director", "security_type": "Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3562.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-24", "executive": "LIU, HUI", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8482.0, "share_price": 7.6, "transaction_value": 64463.2, "transaction_value_label": "$64.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-24", "executive": "LIU, HUI", "executive_title": "Director", "security_type": "Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8482.0, "share_price": 5.6, "transaction_value": 47499.2, "transaction_value_label": "$47.5K", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-24", "executive": "LIU, HUI", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3562.0, "share_price": 2.38, "transaction_value": 8477.56, "transaction_value_label": "$8.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-16", "executive": "CHUNG, WENDY", "executive_title": "Director", "security_type": "Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3562.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}, {"symbol": "RLYB", "name": "Rallybio Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-16", "executive": "CHUNG, WENDY", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3562.0, "share_price": 2.38, "transaction_value": 8477.56, "transaction_value_label": "$8.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T10:57:46.931933+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlyb/", "research_links": {"chart": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/", "report": "/terminal/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/report/", "factor": "/factors/ticker/8ae7d703-1a45-4a80-8791-d5a3afec4d6d/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}